Key Metrics of IDEXX Laboratories, Inc.
Revenue$3.7B▲ 8.7% YoYFY 2023
Operating income$1.1B▲ 22.1% YoY
Net profit$845M▲ 24.4% YoY
Shareholders' equity$1.5B
Market cap$43.4BIDXX · $551.21
Competitors10identified
About IDEXX Laboratories, Inc.
Part of IDEXX Laboratories, Inc..
Sectors
Company details
- Website
- idexx.com
- Founded
- 1991
- Listed
- Nasdaq: IDXX (since 1991)
Operational Areas of IDEXX Laboratories, Inc.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameIDEXX Laboratories Inc.
TickerIDXX
ExchangeNasdaq
CountryUnited States
SEC CIK0000874716
Listed since1991
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.idexx.com
US market & SEC filings
IDXX · Nasdaq · SEC CIK 0000874716
Last price · 02 Nov 2026
$551.21
−4.30%
Market cap$43.4B
P/E54.8On FY 2023 diluted EPS
Volume1,174,197
SectorHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances
Country · IPOUnited StatesListed 1991
IDXX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeWestbrook
GSTIN—
Email—
Websitehttp://www.idexx.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of IDEXX Laboratories, Inc.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
M
Molina HealthcarePharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
T
Tenet HealthcarePharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
K
Krishna Institute Of Medical Sciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Oscar Health Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
B
BrightSpring Health Services Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
A
American Healthcare REIT Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Omega Healthcare Investors Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
K
Koninklijke Philips N.V. NY Registry SharesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of IDEXX Laboratories, Inc.
Business activities and related parties
health care
Filings
No filings on record yet.